Corner Therapeutics
PrivateLast Round
Grant
Apr 18, 2024
Total Funding Raised
$54M
Company Overview
Corner Therapeutics is a biotechnology company that develops novel immunotherapies and mRNA-based vaccines using a proprietary dendritic cell hyperactivation platform to treat cancer and infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Corner Therapeutics Comparables
Compare Corner Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Guardian Bio | 80% | |
| OxVax Ltd. | 80% | |
| UbiVac, Inc. | 78% | |
Corner Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 18, 2024 |
Key People
Founding team and executive leadership
Corner Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Gates Foundation | Grant |
| Cockrell Interests | Grant |
| The Bill & Melinda Gates Foundation Trust | Grant |
| Ziff Capital Partners | Grant |
| Tanis Ventures | Grant |
Corner Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Corner Therapeutics's valuation, stock price, and market status.